About the business:
A leading multinational generic pharmaceutical company, with significant business in the US and a broad product portfolio, seeks to diversify beyond the highly competitive, low-margin generics market. The company aims to develop value-added, innovative products by repurposing approved molecules for new indications, alternative dosage forms, or different patient populations—targeting unmet medical needs.
Problem statement:
Identifying such opportunities requires extensive literature reviews, often taking two to three months and involving multiple iterations to uncover viable product concepts. To accelerate this process, the company plans to adopt an Agentic AI solution that integrates with various online sources and subscription-based databases.
This AI-driven tool will enable users to interactively explore potential innovation cases, significantly reducing research time and increasing throughput. By enhancing the speed and quality of early-stage product evaluations, the company aims to strengthen its pipeline with differentiated offerings that deliver greater clinical and commercial value.
Goal:
Teams must design an Agentic AI solution where the Master Agent:
- Can be linked to various regulatory websites, clinical trial websites, scientific journals and paid databases (subscriptions provided by the client), along with any internal databases of the client
- Features a user interface that allows users to input prompts for finding information from the web, analyzing market data and summarize scientific journals
- Generates a summary report of the searches and save the report in an archival system
Key deliverable:
A live demo or recorded video (maximum four minutes) showcasing the end-to-end journey from the initial prompt of finding a molecule, identifying its unmet needs, checking for ongoing clinical trials, exploring its probable use in other diseases, and determining if any patents have been filed, leading to the development of an innovative product story.